Eurobio Scientific Société anonyme (ALERS.PA)
EUR 23.8
(-5.93%)
EUR 23.8
(-5.93%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.83 Million EUR | -80.61% |
| 2022 | 24.93 Million EUR | -58.81% |
| 2021 | 60.54 Million EUR | -17.61% |
| 2020 | 73.48 Million EUR | 2230.51% |
| 2019 | 3.15 Million EUR | 213.91% |
| 2018 | -2.76 Million EUR | 72.23% |
| 2017 | -9.96 Million EUR | -28.92% |
| 2016 | -7.73 Million EUR | -31.54% |
| 2015 | -5.87 Million EUR | -7.14% |
| 2014 | -5.48 Million EUR | 8.46% |
| 2013 | -5.99 Million EUR | -3.88% |
| 2012 | -5.77 Million EUR | 18.72% |
| 2011 | -7.09 Million EUR | 8.38% |
| 2010 | -7.74 Million EUR | -0.61% |
| 2009 | -7.7 Million EUR | 13.71% |
| 2008 | -8.92 Million EUR | -21.59% |
| 2007 | -7.34 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 3.99 Million EUR | 0.0% |
| 2023 Q4 | 2.64 Million EUR | 0.0% |
| 2023 FY | 4.83 Million EUR | -80.61% |
| 2023 Q2 | 2.19 Million EUR | 0.0% |
| 2022 Q2 | 19.22 Million EUR | 0.0% |
| 2022 FY | 24.93 Million EUR | -58.81% |
| 2022 Q4 | 5.71 Million EUR | 0.0% |
| 2021 Q4 | 27.48 Million EUR | 0.0% |
| 2021 FY | 60.54 Million EUR | -17.61% |
| 2021 Q2 | 33.06 Million EUR | 0.0% |
| 2020 FY | 73.48 Million EUR | 2230.51% |
| 2020 Q4 | 47.79 Million EUR | 0.0% |
| 2020 Q2 | 25.68 Million EUR | 0.0% |
| 2019 FY | 3.15 Million EUR | 213.91% |
| 2019 Q2 | 351 Thousand EUR | 0.0% |
| 2019 Q4 | 2.8 Million EUR | 0.0% |
| 2018 Q4 | -1.87 Million EUR | 0.0% |
| 2018 Q2 | -896 Thousand EUR | 0.0% |
| 2018 FY | -2.76 Million EUR | 72.23% |
| 2017 Q4 | -5 Million EUR | 0.0% |
| 2017 FY | -9.96 Million EUR | -28.92% |
| 2017 Q2 | -4.96 Million EUR | 0.0% |
| 2016 Q2 | -3.9 Million EUR | 0.0% |
| 2016 FY | -7.73 Million EUR | -31.54% |
| 2016 Q4 | -3.82 Million EUR | 0.0% |
| 2015 Q4 | -3.6 Million EUR | 0.0% |
| 2015 Q2 | -2.27 Million EUR | 0.0% |
| 2015 FY | -5.87 Million EUR | -7.14% |
| 2014 Q2 | -1.94 Million EUR | 0.0% |
| 2014 Q4 | -3.54 Million EUR | 0.0% |
| 2014 FY | -5.48 Million EUR | 8.46% |
| 2013 Q4 | -3.26 Million EUR | 0.0% |
| 2013 Q2 | -2.72 Million EUR | 0.0% |
| 2013 FY | -5.99 Million EUR | -3.88% |
| 2012 Q2 | - EUR | 100.0% |
| 2012 FY | -5.77 Million EUR | 18.72% |
| 2012 Q4 | - EUR | 100.0% |
| 2012 Q3 | -1.44 Million EUR | 0.0% |
| 2012 Q1 | -1.44 Million EUR | 0.0% |
| 2011 Q4 | - EUR | 100.0% |
| 2011 Q2 | - EUR | 100.0% |
| 2011 FY | -7.09 Million EUR | 8.38% |
| 2011 Q3 | -1.77 Million EUR | 0.0% |
| 2011 Q1 | -1.77 Million EUR | 0.0% |
| 2010 Q1 | -1.93 Million EUR | 0.0% |
| 2010 FY | -7.74 Million EUR | -0.61% |
| 2010 Q4 | - EUR | 100.0% |
| 2010 Q3 | -1.93 Million EUR | 0.0% |
| 2010 Q2 | - EUR | 100.0% |
| 2009 Q1 | -1.92 Million EUR | 13.72% |
| 2009 Q4 | - EUR | 100.0% |
| 2009 Q3 | -1.92 Million EUR | 0.0% |
| 2009 Q2 | -1.92 Million EUR | 0.0% |
| 2009 FY | -7.7 Million EUR | 13.71% |
| 2008 FY | -8.92 Million EUR | -21.59% |
| 2008 Q1 | -2.23 Million EUR | -21.61% |
| 2008 Q2 | -2.23 Million EUR | 0.0% |
| 2008 Q3 | -2.23 Million EUR | 0.0% |
| 2008 Q4 | -2.23 Million EUR | 0.0% |
| 2007 Q4 | -1.83 Million EUR | 0.0% |
| 2007 Q2 | -1.83 Million EUR | 0.0% |
| 2007 Q3 | -1.83 Million EUR | 0.0% |
| 2007 Q1 | -1.83 Million EUR | 0.0% |
| 2007 FY | -7.34 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | 130.889% |
| Bluelinea Société Anonyme | -1.62 Million EUR | 398.457% |
| Carmat SA | -53.86 Million EUR | 108.975% |
| Diagnostic Medical Systems S.A. | -4.94 Million EUR | 197.756% |
| Euromedis Groupe | 13.11 Million EUR | 63.121% |
| Ikonisys S.A. | -2.26 Million EUR | 313.217% |
| Implanet S.A. | -6.67 Million EUR | 172.424% |
| Median Technologies SA | -22.98 Million EUR | 121.038% |
| SpineGuard SA | -4.18 Million EUR | 215.576% |
| Theraclion SA | -3.67 Million EUR | 231.564% |
| Euroapi S.A. | -189.7 Million EUR | 102.549% |
| Guerbet SA | 23.86 Million EUR | 79.741% |
| Ion Beam Applications SA | -9.11 Million EUR | 153.074% |
| Koninklijke Philips N.V. | -466 Million EUR | 101.038% |
| Sequana Medical NV | -32.56 Million EUR | 114.848% |